David is a clinician researcher based in the South East of Greater London. He qualified form the London Hospital Medical College in 1986. He obtained his MD in Dysphagia following stroke from London University in 1997. He has been published  61 papers in peer reviewed journals as well as numerous presentations to  Learned Societies (British Geriatric Society, European Society of Swallowing Disorders, UK Swallowing Research Group,  Dysphagia Research Society, Society of Acute Medicine). He continues to conduct research into Dysphagia Rehabilitation focussing on sarcopenia, frailty and dysphagia and dysphagia post stroke. David is Chair of the UK Swallowing Research Group and has been a board member of the European Society for Swallowing Disorders and Hon Secretary of the British Association of Stroke Physicians. He has been awarded an honorary Fellowship by the Royal College of Speech and Language Therapists and is a Visiting Research Fellow at Greenwich University.  David has delivered invited lectures (on dysphagia in older people and stroke) in many European countries (including Kazakhstan, Denmark, Switzerland, Germany and Italy). He is a member of various working groups looking into the management of dysphagia in Care Homes and in Acute settings.

Is a Clinician with special interest in psychiatry and neurology. Following an initial period of nine years in the NHS she worked in the pharmaceutical industry in Europe, the US and UK for ten years where she held senior positions in a number of companies with responsibility for the development of new drugs for psychiatry and neurology. She also spent two years with the Medicines Control Agency (Now the MHRA). Since 1994, she has combined part-time clinical practice with her own independent research consultancy (www.psi-napse.com). In her consultancy she specialises in advising about development and medico-marketing strategy for drugs in CNS indications (includes NICE HTAs), is an advisor to venture capital groups and is a member of the Wellcome Trust Pathfinder Awards Committee. In the NHS she has experience as a GP with Special Interest in Mental Health, Dementia and Learning Disability, as a commissioner and as representative for mental health and dementia for NHS England Team South East Region; currently she has national roles as RCGP Clinical Representative for Dementia, Advisor to the Academic Health Science Network Kent Surrey Sussex, and Chair of the Lewy Body Society Specialist Advisory Group.

Dr Fang Liu is an Associate Professor at the University of Hertfordshire and Founder of Fluid Pharma Ltd. She obtained her PhD in Pharmaceutics in 2008 from UCL School of Pharmacy, before undertaking a Post-Doctoral research position in the same institution.  In 2009, Fang joined the University of Hertfordshire as a Lecturer in Clinical Pharmaceutics.  Her research interests focus on developing patient-centric medicines for older adults. She is a co-chair of the Age-Related Medicines Focus Group in Academy of Pharmaceutical Sciences of Great Britain (APSGB). She has published her work in over 25 peer reviewed journal articles and is the inventor of 4 patent applications. In 2016, Fang founded a university spin-out company, Fluid Pharma Ltd, focusing on developing bespoke medicines for older patients. Fluid Pharma has attracted nearly £1 million investment and developed an innovative solution in manufacturing liquid sustained release medicines that are easy to swallow for patients with swallowing difficulties.

Debi Bhattacharya is a senior lecturer in pharmacy practice at the University of East Anglia.

Her grant income and publications focus on the application of health psychology to inform behaviour change of patients and practitioners.  Current active grants relate to medication adherence and deprescribing.

Debi is also a GP practice based clinical pharmacist and chair of the Eastern region of the RPS.